The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
出版年份 2023 全文链接
标题
The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
作者
关键词
-
出版物
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume -, Issue -, Pages 101485
出版商
Elsevier BV
发表日期
2023-06-04
DOI
10.1016/j.beha.2023.101485
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
- (2023) Sebastian Giebel et al. BONE MARROW TRANSPLANTATION
- T-replete cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy
- (2023) Claire Horgan et al. Blood Advances
- Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT
- (2023) Klaus Hirschbühl et al. BONE MARROW TRANSPLANTATION
- Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT
- (2022) Ryszard Swoboda et al. BONE MARROW TRANSPLANTATION
- In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
- (2022) David I Marks et al. Lancet Haematology
- A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
- (2022) Jennifer Whangbo et al. Blood Advances
- KIR-Favorable TCR-αβ/CD19-Depleted Haploidentical HCT in Children with ALL/AML/MDS: Primary Analysis of PTCTC ONC1401
- (2022) Michael A Pulsipher et al. BLOOD
- Should all CAR-T therapy for acute lymphoblastic leukemia Be consolidated with allogeneic stem cell transplant?
- (2022) Alejandro Marinos et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
- (2021) Benjamin Watkins et al. JOURNAL OF CLINICAL ONCOLOGY
- Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
- (2021) Matthew J. Wieduwilt et al. LEUKEMIA
- Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized Study
- (2021) Mitchell E Horwitz et al. BLOOD
- Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
- (2021) Jaime Sanz et al. Journal of Hematology & Oncology
- KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
- (2021) Bijal D Shah et al. LANCET
- Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
- (2021) Matthew J Wieduwilt et al. Blood Advances
- Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
- (2021) Birgitta Versluijs et al. Blood Advances
- Neoantigens in Hematologic Malignancies
- (2020) Melinda A. Biernacki et al. Frontiers in Immunology
- Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
- (2020) Krzysztof Kalwak et al. BONE MARROW TRANSPLANTATION
- Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
- (2020) Zinaida Peric et al. BONE MARROW TRANSPLANTATION
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
- (2020) Andre Manfred Willasch et al. BONE MARROW TRANSPLANTATION
- Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation
- (2020) Effie W. Petersdorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
- (2020) Houli Zhao et al. Journal of Hematology & Oncology
- A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial
- (2020) Daisuke Tomizawa et al. BLOOD
- Review of conditioning regimens for haplo-identical donor transplants using post-transplant cyclophosphamide in recipients of G-CSF mobilised peripheral stem cell
- (2020) Sushrut Patil et al. CANCER TREATMENT REVIEWS
- Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
- (2020) Robin Foà et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001
- (2020) Melissa A. Burns et al. PEDIATRIC BLOOD & CANCER
- A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation
- (2020) Muna Qayed et al. BLOOD
- High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
- (2020) Juliet N. Barker et al. Blood Advances
- Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
- (2019) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
- (2019) Marianne Ifversen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation
- (2019) K. Scott Baker et al. BLOOD
- Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group
- (2019) Jennifer L. McNeer et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting
- (2019) Noa Granot et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
- (2019) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies
- (2019) Jaime Sanz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
- (2019) Effie W Petersdorf et al. Lancet Haematology
- Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
- (2018) Partow Kebriaei et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes After Second Hematopoietic Cell Transplant for Children and Young Adults with Relapsed Acute Leukemia
- (2018) Troy C. Lund et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis
- (2018) Zhenglei Shen et al. BMC CANCER
- Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia
- (2018) Anita Lawitschka et al. Current Oncology Reports
- Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
- (2017) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT
- (2017) Gabrielle Roth-Guepin et al. Oncotarget
- Mechanistic approaches for the prevention and treatment of chronic GVHD
- (2016) Corey S. Cutler et al. BLOOD
- Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
- (2016) Philippe Rousselot et al. BLOOD
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters
- (2016) D Bresters et al. BONE MARROW TRANSPLANTATION
- Nonmyeloablative allogeneic hematopoietic cell transplantation
- (2016) R. Storb et al. HAEMATOLOGICA
- TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients
- (2016) Leylagul Kaynar et al. Hematology
- Cord-Blood Transplantation in Patients with Minimal Residual Disease
- (2016) Filippo Milano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonmyeloablative allogeneic hematopoietic cell transplantation
- (2016) R. Storb et al. HAEMATOLOGICA
- Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research
- (2015) Michael J. Burke et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era
- (2015) Navneet S. Majhail et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study
- (2015) Mohamed L. Sorror et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
- (2015) M. A. Pulsipher et al. BLOOD
- Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
- (2015) N. Dhedin et al. BLOOD
- Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT
- (2015) X Cahu et al. BONE MARROW TRANSPLANTATION
- Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)
- (2015) N Kröger et al. BONE MARROW TRANSPLANTATION
- Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
- (2015) M A Pulsipher et al. BONE MARROW TRANSPLANTATION
- Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors—The ALL-SCT-BFM-2003 Trial
- (2015) Christina Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
- (2015) Yvette L. Kasamon et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
- (2015) Elias Jabbour et al. LANCET ONCOLOGY
- Acute Lymphoblastic Leukemia in Children
- (2015) Stephen P. Hunger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia
- (2014) Heidrun Boztug et al. ANNALS OF HEMATOLOGY
- CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status
- (2014) R. S. Sellar et al. BLOOD
- The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial
- (2014) Michael A. Pulsipher et al. BLOOD
- Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study
- (2014) V. Conter et al. BLOOD
- Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL
- (2014) Y-q Sun et al. BONE MARROW TRANSPLANTATION
- Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cel
- (2014) Motohiro Kato et al. BRITISH JOURNAL OF HAEMATOLOGY
- Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react
- (2014) Cécile Pochon et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol
- (2014) Virginie Gandemer et al. BRITISH JOURNAL OF HAEMATOLOGY
- HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
- (2014) Loren Gragert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome
- (2014) Johann K. Hitzler et al. PEDIATRIC BLOOD & CANCER
- Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission
- (2013) Ki-Seong Eom et al. AMERICAN JOURNAL OF HEMATOLOGY
- Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity
- (2013) I.H. Bartelink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
- (2013) J Tanaka et al. BONE MARROW TRANSPLANTATION
- Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors
- (2013) D. I. Marks et al. HAEMATOLOGICA
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
- (2013) V Bachanova et al. LEUKEMIA
- Unrelated Cord Blood Transplantation in Adult and Pediatric Acute Lymphoblastic Leukemia: Effect of Minimal Residual Disease on Relapse and Survival
- (2012) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review
- (2012) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Transplantation Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia
- (2012) James Tracey et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
- (2012) W. Leung et al. BLOOD
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
- (2012) N. Gokbuget et al. BLOOD
- Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL
- (2012) J Sanchez-Garcia et al. BONE MARROW TRANSPLANTATION
- Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia
- (2012) Emma Corker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia
- (2012) Yu Wang et al. CANCER
- High-dose etoposide in allogeneic stem cell transplantation
- (2012) Øystein Bruserud et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
- (2012) Martin Schrappe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission
- (2011) Eneida R. Nemecek et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission
- (2011) G. Dini et al. BLOOD
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2010) M. Mohty et al. BLOOD
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission
- (2010) D. I. Marks et al. BLOOD
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
- (2010) Michel Duval et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission andMLLGene Rearrangements: A Report From the Children's Oncology Group
- (2010) ZoAnn E. Dreyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
- (2010) A C Lankester et al. LEUKEMIA
- Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
- (2009) Anthony S. Stein et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study
- (2009) B-S Cho et al. LEUKEMIA
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program
- (2008) Margaret L. MacMillan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies
- (2008) J. Kurtzberg et al. BLOOD
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
- (2008) A. Moricke et al. BLOOD
- Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies
- (2008) B Horn et al. BONE MARROW TRANSPLANTATION
- ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN SECOND COMPLETE REMISSION—Similar Outcomes After Matched Related and Unrelated Donor Transplant: A Study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon)
- (2008) A. Muñoz et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started